Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ping Hu

1PUBLICATIONS

12CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 27, 2024

Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma.

Ping Hu, Haiqing Isaac Dai, James Bourdage

Pageof 1

Frequent Collaborators

1 joint publications

Haiqing Isaac Dai

1 joint publications

James Bourdage

1 joint publications

Dongli Zhou

1 joint publications

Ky Trang

1 joint publications

Karey Kowalski

1 joint publications

Carlo Bello

1 joint publications

Jennifer Hibma

1 joint publications

Akash Khandelwal

1 joint publications

Kyra Cowan

1 joint publications

Jennifer Dong

Frequent Collaborators

1 joint publications

Haiqing Isaac Dai

1 joint publications

James Bourdage

1 joint publications

Dongli Zhou

1 joint publications

Ky Trang

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos